GE Healthcare sells its Catalog Radiochemicals, SPA reagents and Cytostar-T plate product lines

PerkinElmer, Inc., a global leader focused on improving the health and safety of people and their environment, today announced that it has purchased the assets of GE Healthcare’s 3H and 14C Catalog Radiochemicals, Scintillation Proximity Assay (SPA) reagents and Cytostar-T plate product lines.

The Catalog Radiochemical products are used for a variety of research applications, including screening of potential drug candidates through binding assays. The SPA bead-based light-emitting assay and Cytostar-T plate technologies are offerings that enable the automation of High Throughput Screening (HTS) processes, to help drug discovery researchers quickly and accurately determine if potential new drug compounds are effective against their intended disease targets.

GE Healthcare will be working closely with PerkinElmer to ensure a smooth transition of its manufacturing and technical support activities and to minimize disruption for customers during the transition period.

Richard M. Eglen, PhD, president, Bio-discovery, PerkinElmer, said, "PerkinElmer is delighted to announce this enhancement to our reagents assets. We expect that the incorporation of these technologies will strengthen our industry-leading GPCR and Kinase research product lines, and complement our HTS and research reagent solutions. This asset purchase reinforces PerkinElmer's continued position as the leading company in HTS radiochemicals and related instruments, as we remain committed to supporting critical radiochemicals-based research."

As a result of this asset purchase, PerkinElmer will now provide the world’s largest selection of high-quality radiolabeled compounds to the global scientific community. In addition, the company plans to continue to expand its NEN® radiochemical portfolio, as well as offer its extensive lines of readers, nuclear counters and other high-performance instrumentation that provide customers with complete application solutions in radiometric detection. For more information, please visit: www.perkinelmer.com/committedtorads.

www.perkinelmer.com

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    PerkinElmer. (2009, September 17). GE Healthcare sells its Catalog Radiochemicals, SPA reagents and Cytostar-T plate product lines. News-Medical. Retrieved on December 10, 2019 from https://www.news-medical.net/news/20090917/GE-Healthcare-sells-its-Catalog-Radiochemicals-SPA-reagents-and-Cytostar-T-plate-product-lines.aspx.

  • MLA

    PerkinElmer. "GE Healthcare sells its Catalog Radiochemicals, SPA reagents and Cytostar-T plate product lines". News-Medical. 10 December 2019. <https://www.news-medical.net/news/20090917/GE-Healthcare-sells-its-Catalog-Radiochemicals-SPA-reagents-and-Cytostar-T-plate-product-lines.aspx>.

  • Chicago

    PerkinElmer. "GE Healthcare sells its Catalog Radiochemicals, SPA reagents and Cytostar-T plate product lines". News-Medical. https://www.news-medical.net/news/20090917/GE-Healthcare-sells-its-Catalog-Radiochemicals-SPA-reagents-and-Cytostar-T-plate-product-lines.aspx. (accessed December 10, 2019).

  • Harvard

    PerkinElmer. 2009. GE Healthcare sells its Catalog Radiochemicals, SPA reagents and Cytostar-T plate product lines. News-Medical, viewed 10 December 2019, https://www.news-medical.net/news/20090917/GE-Healthcare-sells-its-Catalog-Radiochemicals-SPA-reagents-and-Cytostar-T-plate-product-lines.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.
Post a new comment
Post
You might also like... ×
PerkinElmer to showcase new mass spectrometry solutions at ASMS conference